XRF Scientific (XRF) AGM 2026 presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2026 presentation summary
18 Oct, 2026Technology and products
Sample preparation and analysis technologies serve mining, manufacturing, commercial labs, research and education; applications include iron ore, gold, nickel, copper, cement, metals and glass, using XRF, ICP, fire assay and photon assay.
Orbis crushers reduce 110 mm drill-core samples to 2 mm in one pass, with automated splitting, loader options and a design for continuous use in harsh mining conditions.
Lab products include platinum labware, X-ray flux and fusion machines, plus recycling used platinum products into new items.
XRTGA supports analysis of moisture, volatiles, ash, fixed carbon and loss on ignition; applications include mining, construction materials, food, plastics and agriculture.
CGA elemental analysis covers carbon, sulphur, oxygen, nitrogen and hydrogen for quality control across metals, alloys, welding, magnetic materials and additive manufacturing.
FY26 highlights
Strong mining and industrial demand, international sales growth in developing markets, particularly Asia, and continued growth in Orbis crusher sales.
Acquired the CGA Elemental Analysis Instrument business from Bruker AXS SE on 23 April 2026 for upfront consideration of US$4m; opened offices in India and the US.
FY26 revenue rose 8% YoY to $64.4m; adjusted NPBT increased 10% to $16.1m.
NPAT increased 1% to $10.5m after acquisition and international-office startup costs; effective tax rate rose to 32% from 29%.
Gross margin was 49.3% vs 48.4% in FY25; fully franked dividend was 4.5 cents per share, and Q4 adjusted PBT reached a record $4.7m on $17.2m revenue.
Balance sheet and cash flow
Net cash position was $8.5m at FY26 year-end; cash and cash equivalents were $9.5m vs $12.2m in FY25.
CGA acquisition was funded entirely in cash and added $6.2m to intangible assets, $1.0m to inventories and $1.4m to other payables for acquisition earnout liability.
Operating cash inflow was $11.4m vs $10.1m in FY25; investing outflow was $8.1m, including $5.6m for the CGA acquisition.
Financing cash outflow was $6.0m, including $5.0m paid for the FY25 dividend; cash ended the period at $9.5m.
Latest events from XRF Scientific
- Revenue rose 38% YoY as all divisions grew, with CGA and Orbis bolstering the December outlook.XRF
Trading update - FY26 delivered record revenue, margin gains, and global expansion, setting up for further growth.XRF
Investor presentation - Record revenue and profit growth, with strong outlook from international and new products.XRF
H2 2026 - Revenue and profit growth accelerate as new acquisitions and product launches expand global reach.XRF
Investor presentation - Record revenue, profit, and dividend growth fueled by mining demand and global expansion.XRF
H2 2025 - Record revenue and profit growth, higher dividend, and full Orbis Mining ownership boost outlook.XRF
H2 2024 - Strong 1H26 growth in revenue and profit, with expansion in precious metals and equipment.XRF
Investor presentation - Record revenue and profit growth driven by mining demand, international expansion, and new products.XRF
H1 2026 - Record profit and revenue growth driven by mining demand, acquisitions, and recurring sales.XRF
H1 2025